found glp 1 GLP-1 medicines entered clinical use in 2005 as treatments for Type 2 diabetes. Over time, doctors observed their effects on appetite and body weight, leading to separate approvals for obesity Save $100 on your first

This widespread and off-label interest in weight loss drugs has also led to an explosion of unapproved products available online and via social media, which do come with safety risks for consumers

A large study of 2000 patients without diabetes showed that using Ozempic/Wegovy in addition to diet and exercise for 68 weeks led to a 15% weight loss (1/3 of the participants lost up to 20% of their starting weight.) Those in the control group that were only coached on the lifestyle changes lost 2.4% of their weight

When youre eating less, you still need those building blocks, sometimes even more than before

Christensen M, Sparre-Ulrich AH, Hartmann B, Grevstad U, Rosenkilde MM, Holst JJ, et al

Review the MOTS-C side effects page for the most current safety information available

Future research must prioritize rigorous translational frameworks that integrate molecular, neurophysiological, and behavioral data across species